RNS Number:9258N
BioProgress PLC
24 July 2003


                BioProgress PLC ("BioProgress" or the "Company")

Pursuant to the exercise of options over 454,626 ordinary shares of 1p each in
the Company, application has been made for these new ordinary shares ("New
Shares") to be admitted to the Alternative Investment Market ("AIM"). The option
exercise price is 16 pence per share.

Admission of the New Shares is expected to become effective on 31 July 2003.

24 July 2003


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
LISSEDFELSDSEEW